CY1120616T1 - PHARMACEUTICAL FORM DOSAGE WHICH INCLUDES 6'-Fluoro- (N-METHYL- Ή N, N-DIMETHYL-) - 4-PHENYL-4 ', 9'-DIHYDRO-3'H-SP1 PYRANO [3,4, Β] INDOL] -4-AMINE FOR THE TREATMENT OF NEUROPATHY PAIN - Google Patents

PHARMACEUTICAL FORM DOSAGE WHICH INCLUDES 6'-Fluoro- (N-METHYL- Ή N, N-DIMETHYL-) - 4-PHENYL-4 ', 9'-DIHYDRO-3'H-SP1 PYRANO [3,4, Β] INDOL] -4-AMINE FOR THE TREATMENT OF NEUROPATHY PAIN

Info

Publication number
CY1120616T1
CY1120616T1 CY181100617T CY181100617T CY1120616T1 CY 1120616 T1 CY1120616 T1 CY 1120616T1 CY 181100617 T CY181100617 T CY 181100617T CY 181100617 T CY181100617 T CY 181100617T CY 1120616 T1 CY1120616 T1 CY 1120616T1
Authority
CY
Cyprus
Prior art keywords
pyrano
indol
dihydro
fluoro
dimethyl
Prior art date
Application number
CY181100617T
Other languages
Greek (el)
Inventor
Nadja Grüning
Marc Schiller
Ingo Friedrich
Chris Kirby
Ashish Hemani
John Bothmer
Andreas Scholz
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11746174.9A external-priority patent/EP2600851B1/en
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of CY1120616T1 publication Critical patent/CY1120616T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η εφεύρεση αφορά μία φαρμακευτική μορφή δοσολογίας για χορήγηση μία φορά την ημέρα που περιέχει 6'-φθορο-(Ν-μεθυλ- ή Ν,Ν-διμεθυλ-)-4-φαινυλ-4',9'-διυδρο-3Ή-σπειρο[κυκλοεξανο-1,1'-πυρανο[3,4,b]ινδολ]-4-αμίνη ή ένα φυσιολογικά αποδεκτό άλας αυτής για χρήση στην αγωγή του νευροπαθητικού πόνου.The invention relates to a pharmaceutical dosage form for once daily administration containing 6'-fluoro- (N-methyl- or N, N-dimethyl-) -4-phenyl-4 ', 9'-dihydro-3D-helix [ cyclohexane-1,1'-pyrano [3,4, b] indol] -4-amine or a physiologically acceptable salt thereof for use in the treatment of neuropathic pain.

CY181100617T 2010-08-04 2018-06-13 PHARMACEUTICAL FORM DOSAGE WHICH INCLUDES 6'-Fluoro- (N-METHYL- Ή N, N-DIMETHYL-) - 4-PHENYL-4 ', 9'-DIHYDRO-3'H-SP1 PYRANO [3,4, Β] INDOL] -4-AMINE FOR THE TREATMENT OF NEUROPATHY PAIN CY1120616T1 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US37063410P 2010-08-04 2010-08-04
US37064810P 2010-08-04 2010-08-04
US37064310P 2010-08-04 2010-08-04
EP10008116 2010-08-04
EP10008115 2010-08-04
EP10008117 2010-08-04
EP11746174.9A EP2600851B1 (en) 2010-08-04 2011-08-04 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain
PCT/EP2011/003908 WO2012016698A2 (en) 2010-08-04 2011-08-04 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain

Publications (1)

Publication Number Publication Date
CY1120616T1 true CY1120616T1 (en) 2019-12-11

Family

ID=65444400

Family Applications (2)

Application Number Title Priority Date Filing Date
CY181100617T CY1120616T1 (en) 2010-08-04 2018-06-13 PHARMACEUTICAL FORM DOSAGE WHICH INCLUDES 6'-Fluoro- (N-METHYL- Ή N, N-DIMETHYL-) - 4-PHENYL-4 ', 9'-DIHYDRO-3'H-SP1 PYRANO [3,4, Β] INDOL] -4-AMINE FOR THE TREATMENT OF NEUROPATHY PAIN
CY181101280T CY1120970T1 (en) 2010-08-04 2018-12-03 PHARMACEUTICAL DOSAGE FORM INCLUDING 6'-Fluoro- (N-METHYL-Ή N, N-DIMETHYL -) - 4-PHENYL-4 ', 9'-DIHYDRO-3-KY-SPO , 4, B] INDOL] -4-AMINH FOR THE TREATMENT OF ALGESTIC PAIN

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY181101280T CY1120970T1 (en) 2010-08-04 2018-12-03 PHARMACEUTICAL DOSAGE FORM INCLUDING 6'-Fluoro- (N-METHYL-Ή N, N-DIMETHYL -) - 4-PHENYL-4 ', 9'-DIHYDRO-3-KY-SPO , 4, B] INDOL] -4-AMINH FOR THE TREATMENT OF ALGESTIC PAIN

Country Status (4)

Country Link
CY (2) CY1120616T1 (en)
ES (1) ES2702528T3 (en)
HU (1) HUE041960T2 (en)
PT (1) PT2600850T (en)

Also Published As

Publication number Publication date
CY1120970T1 (en) 2019-12-11
PT2600850T (en) 2018-12-04
HUE041960T2 (en) 2019-06-28
ES2702528T3 (en) 2019-03-01

Similar Documents

Publication Publication Date Title
MX354686B (en) Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1 '-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain.
CY1121858T1 (en) ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS CONTAINING THEM AND METHODS OF USING THEM
NZ605841A (en) Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
ECSP13012421A (en) PHARMACEUTICAL DOSAGE FORM INCLUDING 6'-FLUORO- (N-METHYL-ON, N-DIMETILE) -4-PHENYL-4 ', 9'-DIHIDRO-3'H-ESPIRO [CICLOHEXAN-1,1'-PIRANO [ 3,4, b] INDOL] -4-AMINA
EA201200937A1 (en) SOLID MEDICINE FORM TICAGRELOR
CY1120094T1 (en) PHARMACEUTICAL COMPOSITION INCLUDING DESPR036 EXPANDH-4 (1-39) -LYS6-NH2 FOR USE IN THE TREATMENT OF A NEUROCOLOGICAL PATIENT
PH12015500823A1 (en) Modified release formulations for oprozomib
CY1119887T1 (en) PHARMACEUTICAL FORM OF DOSAGE CONTAINING 6'-FLYOR- (N-Methyl-N, N-Dimethyl -) - 4-FENYLO-4 ', 9'-DYYRO-3'-DYYL-3'H [3,4, b] INDOL] -4-AMINE
DK2244703T3 (en) Drug and the preparation and use thereof in the treatment of painful neuropathies
CY1119777T1 (en) PHARMACEUTICAL COMPOSITION OF INCLUSIVE (1R, 4R) -6'-PTHO-N, N-Dimethyl-4-phenyl-4 ', 9'-dihydro-3'H-spiro [cyclohexene-1,1-1,4-1,4- B] INDOL] -4-AMINE AND GABAPENTINOIDS
CY1120616T1 (en) PHARMACEUTICAL FORM DOSAGE WHICH INCLUDES 6'-Fluoro- (N-METHYL- Ή N, N-DIMETHYL-) - 4-PHENYL-4 ', 9'-DIHYDRO-3'H-SP1 PYRANO [3,4, Β] INDOL] -4-AMINE FOR THE TREATMENT OF NEUROPATHY PAIN
EA201291420A1 (en) ORAL MEDICAL FORMS CONTAINING LERCANIDIPIN AND ENALAPRIL AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
EA201590732A1 (en) DISPENSABLE TABLET
CY1119610T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING (1R, 4R) -6'-FLUORO-N, N-DIMETHYL-4-PHENYL-4 ', 9'-DYHYDRO-3'H-SPYRO [CYCLOXAN-1,1'-1'-1-1'-1-1'-1 , 4, B] INDOL] -4-AMINE PARAKETAMOL OR PROPAKETAMOL
CY1118799T1 (en) (1R, 4R) -6'-Fluoro- (N-Methyl-N, N-Dimethyl -) - 4-phenyl-4 ', 9'-dihydro-3'H-spiro- [CYCLOEXANO-1,1' PYRANO [3,4, B] INDOL] -4-AMINE FOR TREATMENT OF FIOMOYLGY AND YOUNG COUPE SYNDROME
CY1116996T1 (en) PHARMACEUTICAL DOSAGE CONTAINING 6'-FLUOR- (N-METHYL-N, N-DIMETHYL -) - 4-FINYL-4 ', 9', - DYYDRO-3'H-SPYRO [3,4-B] INDOL] -4-AMINE PYRANO
CY1117385T1 (en) 6'-Fluoro- (N-Methyl-,N, N-Dimethyl -) - 4-phenyl-4΄, 9'-dihydro-3'-spiro [6-fluoro] PHARMACEUTICAL DOSAGE FORM 4, B] INDOL] -4-AMINE
EA201401269A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING (1R, 4R) -6'-Fluoro-N, N-Dimethyl-4-phenyl-4 ', 9'-DIHYDRO-3'H-SPIRO [CYCLOGEXAN-1,1'-PIRANO [3, 4, B] INDOL] -4-AMIN AND ANTIDEPRESSANTS
CY1117605T1 (en) Crohn's disease treatment with LAQUINIMOD
EA200900173A1 (en) PHARMACEUTICAL COMPOSITION FOR ORAL APPLICATION
EA201992775A2 (en) HUMAN ANTIBODIES CONJUGATES AGAINST TISSUE FACTOR WITH MEDICINES